We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-18.36%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.55B
AUM Growth
-$672M
Cap. Flow
+$187M
Cap. Flow %
5.27%
Top 10 Hldgs %
9.93%
Holding
339
New
24
Increased
143
Reduced
97
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Healthcare 18.9%
3 Financials 14.76%
4 Industrials 14.69%
5 Consumer Discretionary 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSUR icon
126
OraSure Technologies
OSUR
$275M
$12.5M 0.35%
1,069,294
-6,424
-0.6% -$85.4K
ZUO
127
DELISTED
Zuora, Inc.
ZUO
$12.2M 0.35%
674,835
+141,175
+26% +$2.71M
MDRX
128
DELISTED
Veradigm Inc. Common Stock
MDRX
$12M 0.34%
+1,246,105
New +$13.9M
CIR
129
DELISTED
CIRCOR International, Inc
CIR
$12M 0.34%
562,352
+149,100
+36% +$4.96M
ATHN
130
DELISTED
Athenahealth, Inc.
ATHN
$11.8M 0.33%
89,656
-44,711
-33% -$5.73M
DOOR
131
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$11.8M 0.33%
263,179
-1,670
-0.6% -$90.3K
ATVI
132
DELISTED
Activision Blizzard
ATVI
$11.6M 0.33%
249,514
+6,213
+3% +$372K
MTZ icon
133
MasTec
MTZ
$21.5B
$11.4M 0.32%
279,863
+92,945
+50% +$4M
TYL icon
134
Tyler Technologies
TYL
$13B
$11.3M 0.32%
60,733
+1,512
+3% +$299K
ACAD icon
135
Acadia Pharmaceuticals
ACAD
$5.06B
$11M 0.31%
679,605
-73,709
-10% -$1.43M
CERS icon
136
Cerus
CERS
$508M
$10.9M 0.31%
2,143,325
+474,106
+28% +$2.75M
NVTR
137
DELISTED
Nuvectra Corporation Common Stock
NVTR
$10.8M 0.31%
663,702
+65,893
+11% +$1.26M
ICPT
138
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.8M 0.31%
107,553
+7,615
+8% +$789K
MSGN
139
DELISTED
MSG Networks Inc.
MSGN
$10.7M 0.3%
455,772
+151,098
+50% +$3.86M
IT icon
140
Gartner
IT
$12.2B
$10.6M 0.3%
83,272
+2,072
+3% +$299K
PTLA
141
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$10.6M 0.3%
+544,363
New +$11.2M
HDP
142
DELISTED
Hortonworks, Inc.
HDP
$9.94M 0.28%
689,502
-49,509
-7% -$854K
EHTH icon
143
eHealth
EHTH
$40.4M
$9.86M 0.28%
256,731
+85,461
+50% +$2.87M
PENN icon
144
PENN Entertainment
PENN
$2.53B
$9.84M 0.28%
522,646
+236,669
+83% +$5.63M
DY icon
145
Dycom Industries
DY
$12B
$9.57M 0.27%
177,089
-1,063
-0.6% -$71.4K
AMAL icon
146
Amalgamated Financial
AMAL
$1.48B
$9.47M 0.27%
485,613
+312,971
+181% +$6.14M
GTN icon
147
Gray Television
GTN
$512M
$9.26M 0.26%
628,269
+91,361
+17% +$1.59M
AXGN icon
148
Axogen
AXGN
$2.59B
$8.88M 0.25%
434,562
+113,063
+35% +$3.54M
FLXN
149
DELISTED
Flexion Therapeutics, Inc.
FLXN
$8.75M 0.25%
773,045
-4,730
-0.6% -$74.2K
PCRX icon
150
Pacira BioSciences
PCRX
$974M
$8.65M 0.24%
201,139
-23,608
-11% -$1.1M

Similar funds

Peregrine Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Peregrine Capital Management held 339 positions worth $3.55B, down 16% from $4.22B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Peregrine Capital Management deployed $187M of net new capital in Q4 2018, opening 24 new positions and adding to 143 existing holdings. Its largest new stake was MGP Ingredients: 271,397 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Diamondback Energy, an estimated $20.1M trimmed.

  • Peregrine Capital Management's largest Q4 2018 buy was MGP Ingredients: 271,397 shares worth $15.5M.
  • Peregrine Capital Management added most to SVB Financial Group in Q4 2018, an estimated $20M increase.
  • Peregrine Capital Management's biggest Q4 2018 reduction was Diamondback Energy, cutting an estimated $20.1M.
  • Peregrine Capital Management fully exited 2U Inc in Q4 2018, selling an estimated $28M.
  • Peregrine Capital Management's ten largest holdings make up 9.9% of its $3.55B portfolio in Q4 2018.
  • Peregrine Capital Management opened 24 new positions and closed 30 in Q4 2018.
  • Peregrine Capital Management's portfolio value fell 16% quarter-over-quarter to $3.55B.

Based on Peregrine Capital Management's 13F filing for Q4 2018, filed 17 Jan 2019.